Germany: LTS acquires Tapemark to support growth plans

LTS Lohmann Therapie-Systeme (LTS), a pharmaceutical technology company, has acquired Tapemark, a US-based CDMO specializing in transdermal drug delivery systems. Financial details of the transaction are not disclosed. With the acquisition, Tapemark’s St Paul facility becomes part of the worldwide operations network of LTS, along with its existing facilities in Andernach, Germany and West Caldwell, NJ in the US. “This strategic…

You must be a HMI Subscriber to view this content.

Subscribe Now »